Alicia B. Berger, Ph.D. - Publications
Affiliations: | 2008 | Stanford University, Palo Alto, CA |
Area:
Biochemistry, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2009 | Edgington LE, Berger AB, Blum G, Albrow VE, Paulick MG, Lineberry N, Bogyo M. Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nature Medicine. 15: 967-73. PMID 19597506 DOI: 10.1038/Nm.1938 | 0.539 | |||
2007 | Sexton KB, Kato D, Berger AB, Fonovic M, Verhelst SHL, Bogyo M. Specificity of aza-peptide electrophile activity-based probes of caspases Cell Death and Differentiation. 14: 727-732. PMID 17170749 DOI: 10.1038/Sj.Cdd.4402074 | 0.599 | |||
2006 | Berger AB, Sexton KB, Bogyo M. Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity Cell Research. 16: 961-963. PMID 17117159 DOI: 10.1038/Sj.Cr.7310112 | 0.521 | |||
2006 | Berger AB, Witte MD, Denault JB, Sadaghiani AM, Sexton KM, Salvesen GS, Bogyo M. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Molecular Cell. 23: 509-21. PMID 16916639 DOI: 10.1016/J.Molcel.2006.06.021 | 0.572 | |||
2005 | Kato D, Boatright KM, Berger AB, Nazif T, Blum G, Ryan C, Chehade KA, Salvesen GS, Bogyo M. Activity-based probes that target diverse cysteine protease families. Nature Chemical Biology. 1: 33-8. PMID 16407991 DOI: 10.1038/Nchembio707 | 0.549 | |||
2004 | Berger AB, Vitorino PM, Bogyo M. Activity-based protein profiling: applications to biomarker discovery, in vivo imaging and drug discovery. American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice. 4: 371-81. PMID 15651898 DOI: 10.2165/00129785-200404060-00004 | 0.485 | |||
Show low-probability matches. |